EuroBio Eurobio Gets CE Mark for Multiplexed SARS-CoV-2, Influenza A/B, RSV Test The test can be used directly on any open instrument, including portable systems, and it allows for detection of pathogens in about 75 minutes. Eurobio Scientific to Commercialize CirrusDx Molecular Biology Instrument in France, North Africa Eurobio Scientific will also develop new test kits for the T-COR 8, a real-time PCR thermocycler originally developed for the US Army. IP Roundup: Panasonic, Ambergen, Illumina, Corning, Seng Enterprises, Charm Sciences, and More Premium Panasonic of Osaka, Japan, has received US Patent Nos. Exonhit Buying InGen for $23.1M, Creating New Dx Firm Diaxonhit NEW YORK (GenomeWeb News) – French biotech firm Exonhit announced today an agreement to acquire InGen BioSciences for €18 million ($23.1 million), forming a new firm called Diaxonhit. Exonhit Granted $2.4M as Part of Project to Develop New Cancer Therapies, Companion Diagnostic NEW YORK (GenomeWeb News) – Exonhit today said it has been awarded €1.9 million ($2.4 million) to participate in a project aimed at developing new treatments for cancers and tools to identify patients who may be best candidates for the treatments. Mar 5, 2012 ExonHit Gets $553K Grant for Participation in RESPONSIFY Project Nov 1, 2011 Exonhit, Cleveland Clinic to Conduct US Clinical Trial of AclarusDx Alzheimer's Test Premium Oct 10, 2011 Exonhit, Pfizer Collaborate on Alzheimer's Biomarkers Aug 2, 2011 BGI 'Interested' in Combining Exonhit's SpliceArray with Sequencing Efforts for Biomarker Discovery Premium Jul 25, 2011 Exonhit, BGI Complete Project to Shed Light on Gene Deregulation Jul 6, 2011 Almac to Perform Exonhit's AclarusDx Alzheimer's Test, Deliver Results to EU Docs Premium Jul 5, 2011 Exonhit Taps Almac Diagnostics as Reference Lab for New Alzheimer's Test Premium Jun 29, 2011 Almac Dx Serving as Sole Reference Lab for Exonhit's Test for Alzheimer's Oct 25, 2010 ExonHit, RedPath Terminate Acquisition Deal Sep 21, 2010 Medicare Maintains Coverage on RedPath's Pancreatic Cancer Test Jun 24, 2010 ExonHit Shareholder Meeting on RedPath Buy Likely Delayed Jun 18, 2010 ExonHit, RedPath Deal Hits Snag as Medicare May Drop Coverage of Test Jun 14, 2010 ExonHit, Genmab Reach Agreement on Breast Cancer Splice Variants Jun 9, 2010 ExonHit Announces Final Terms for RedPath Acquisition Apr 27, 2010 French Biotech ExonHit to Acquire RedPath for $32M to Boost US Presence Premium Apr 26, 2010 ExonHit to Buy RedPath Integrated Pathology Mar 9, 2010 ExonHit, BioMerieux Kill Colon Cancer Program, Continue to Develop Prostate Cancer Dxs Premium Mar 8, 2010 ExonHit, BioMerieux Call off Colon Cancer Collaboration Feb 16, 2010 ExonHit Preps Affy-Based Alzheimer's Test for 2011 Launch Premium Feb 11, 2010 ExonHit to Participate in European Alzheimer's Research Effort Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.